Inhibikase Therapeutics Inc Earnings

The next earnings date for Inhibikase Therapeutics Inc has not yet been scheduled.

Analyst Estimates of Inhibikase Therapeutics Inc Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Inhibikase Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
11/13/2025	After Market	---	---
06/06/2025	After Market	$-0.15	-57.89%
03/25/2025	Before Market	---	---
11/12/2024	Before Market	$-0.65	-75.68%
08/14/2024	After Market	$-0.66	1.49%
05/15/2024	After Market	$-0.73	7.59%
03/27/2024	After Market	$-0.64	24.71%
11/14/2023	After Market	$-0.86	23.21%
08/14/2023	After Market	$-1.11	-20.65%
05/15/2023	Before Market	$-0.16	-14.29%
03/31/2023	Before Market	$-0.18	5.26%
11/14/2022	After Market	$-0.18	0.00%
08/12/2022	After Market	$-0.18	5.26%
05/16/2022	After Market	$-0.18	-5.88%
03/31/2022	After Market	$-0.20	-17.65%
11/15/2021	After Market	$-0.18	-28.57%
08/16/2021	After Market	$-0.22	42.11%
05/17/2021	After Market	$-0.26	---
03/31/2021	After Market	$-0.15	---
12/04/2020	---	$-0.08	---
07/23/2020	---	$-0.13	---
06/30/2020	---	$-0.05	---
03/31/2020	---	$-0.07	---
12/31/2019	---	$-0.05	---
09/30/2019	---	$-0.15	---
06/30/2019	---	$-0.29	---
03/31/2019	---	$-0.21	---
10/16/2018	---	$-0.10	---
03/31/2018	---	$-0.02	---
03/31/2017	---	$-0.02	---

More About Inhibikase Therapeutics Inc

Website

https://www.inhibikase.com

Country

USA

Full Time Employees

Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a non-receptor Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia. Inhibikase Therapeutics, Inc. has research and development collaborations with Johns Hopkins University, Arizona State University, and Michigan State University; and a collaborative research and development agreement with Sphaera Pharma Pte. Ltd. The company was founded in 2008 and is based in Atlanta, Georgia.

“Inhibikase Therapeutics Inc Earnings” Can Refer to the Inhibikase Therapeutics Inc Earnings Date

Some people say “Inhibikase Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Inhibikase Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Inhibikase Therapeutics Inc Stock on the Earnings Date

If you own Inhibikase Therapeutics Inc stock (IKT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Inhibikase Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Inhibikase Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Inhibikase Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Inhibikase Therapeutics Inc earnings or anything else related to the stock market.